Alzheimer's Disease

SAN DIEGO — Identifying regions vulnerable to beta-amyloid deposits in younger populations may help predict future accumulation, according to study results presented at the Alzheimer’s Association International Conference.

Quanterix Corp. announced the validation of a laboratory-developed test to quantitatively measure phospho-Tau 181 concentration in plasma to aid in the diagnosis of Alzheimer’s disease.

The NIH awarded a $45 million grant over 5 years to Burke Neurological Institute to evaluate benfotiamine, a synthetic precursor of thiamine, as a potential therapy for mild Alzheimer’s disease or mild cognitive impairment.

The NIH has awarded researchers at the University of Illinois Urbana-Champaign more than $420,000 to develop ultrasound imaging methods to study neurovascular changes underlying Alzheimer’s disease.

A new study demonstrated that obstructive sleep apnea has an acute effect on biomarkers for Alzheimer’s disease and the ability to measure such biomarkers from blood.

Drugs that target the noradrenergic system may improve cognition and apathy in patients with dementia or mild cognitive impairment caused by Alzheimer’s disease but have little effect on attention or episodic memory, researchers reported.

Mdoloris, a company specializing in medical pain monitoring technologies, announced its latest device, a bracelet that can record and track the pain and well-being of those who are unable to verbalize or indicate what they are feeling.

Acadia Pharmaceuticals Inc. announced the outcome of the FDA advisory committee meeting on the use of pimavanserin for treating hallucinations and delusions associated with Alzheimer’s disease psychosis.

HHS announced that Medicare Part B premiums paid in 2022 should be lowered in 2023 to account for an overestimate in costs related to inclusion of Aduhelm within the Medicare program for reimbursement.

Biotech company PharmaJet announced that its partner, the Institute for Molecular Medicine, was awarded a $12 million grant from the NIH National Institute on Aging for a vaccine to prevent Alzheimer’s disease.